I had Erbitux and radiation 12 weeks ago. I interfaced with other head and neck cancer patients that were ahead of me in recovery at a time when Erbitux was not available. These patients went through horrendous complications from regular chemotherapy. The side effects of Erbitux are minimal in comparison. The statistics in the U.S. for 5yr plus survival outweigh the original therapy.
Any treatment is not 100% guaranteed but if the regimin and testing that our government puts new medications through has found this to be more beneficial statistically I cannot understand holding back on the release in England. What does this committee have to substatiate non approval?